No one trust Misleading, he is not delivering on his own timeline, he promises so many things in every conf call but never follow through. Anavex is just one man show, rest are seat warmers...friends and family business.
Just leave, sell everything, don’t come back and buy all the SAVA you can! You will be in heaven. You are going to the Center of the ALZHEIMER UNIVERSE. You will get ALZHEIMERS and keep it forever. You may only lose a little A-Beta. Stay with SAVA!
The obvious answer is that most money managers and people don't believe that Anavex is going to $1249 or $129 and apparently $12.49.
Your faith in the market knowing more than us is I believe miss placed. I have listed several times the items that are keeping the share price where it is. Those items are what most money managers know.
The bottom line is that for most money mangers and many biotech investors Anavex is still a high risk stock. I listed the reasons they believe that.
Once the MOA is proven in a P3 trial and an NDA is filed the opinions will change and the share price will reflect that change. Till then we languish.
Trial results are all that matter. The rest is entertainment.
News 
Market Data 
Discover 
AI
